By: ifood.tv

Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil

Jul 12, 2013 No Comments by

The purpose of this study is to provide Sildenafil therapy for subjects who completed
A1481156 study and are judged by the investigator to derive clinical benefit from continued
treatment with Sildenafil, prior to reimbursement and availability for subjects in the
Russian Federation.

Clinical Trial Conditions: Pulmonary Arterial Hypertension (PAH)

Treatments in this Clinical Trial : Sildenafil

Clinical Trial Phase: Phase 4

Eligible Clinical Trial Participant Age : Between 10 years to 30 years

Can Healthy Volunteers Participate: No

Clinical Trial Lead Sponsor: Pfizer

Detailed Clinical Trial Description: The purpose of this study is to provide Sildenafil therapy for subjects who completed
A1481156 study and are judged by the investigator to derive clinical benefit from continued
treatment with Sildenafil, prior to reimbursement and availability for subjects in the
Russian Federation.

The clinical trial information was obtained from http://clinicaltrials.gov/ct2/show/NCT01897740

New Clinical Trial

About the author

The author didnt add any Information to his profile yet
No Responses to “Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil”

Leave a Reply

By: ifood.tv